🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/02/2013 | 13,31 | 13,66 | 13,31 | 13,36 | -0,09% | 2,58% | 106.119 |
| 19/02/2013 | 13,67 | 13,67 | 13,28 | 13,37 | -2,19% | 2,88% | 282.609 |
| 15/02/2013 | 13,89 | 13,89 | 13,64 | 13,67 | -0,68% | 1,75% | 202.459 |
| 14/02/2013 | 12,91 | 13,85 | 12,70 | 13,77 | +6,36% | 8,89% | 333.264 |
| 13/02/2013 | 12,84 | 12,99 | 12,72 | 12,94 | +1,02% | 2,14% | 128.561 |
| 12/02/2013 | 12,70 | 12,96 | 12,68 | 12,81 | +0,29% | 2,21% | 92.012 |
| 11/02/2013 | 13,01 | 13,08 | 12,72 | 12,78 | -1,16% | 2,73% | 79.829 |
| 08/02/2013 | 12,69 | 13,09 | 12,60 | 12,93 | +2,07% | 3,83% | 127.278 |
| 07/02/2013 | 13,03 | 13,08 | 12,61 | 12,66 | -2,54% | 3,59% | 173.124 |
| 06/02/2013 | 12,51 | 13,01 | 12,51 | 12,99 | +3,48% | 4,04% | 193.162 |
| 05/02/2013 | 12,56 | 12,63 | 12,50 | 12,56 | +0,65% | 1,04% | 75.501 |
| 04/02/2013 | 12,52 | 12,68 | 12,43 | 12,48 | -1,23% | 1,99% | 144.430 |
| 01/02/2013 | 12,61 | 12,72 | 12,35 | 12,63 | +0,75% | 2,92% | 172.643 |
| 31/01/2013 | 12,49 | 12,69 | 12,45 | 12,54 | +0,60% | 1,95% | 291.746 |
| 30/01/2013 | 12,58 | 12,58 | 12,30 | 12,46 | -0,99% | 2,23% | 198.932 |
| 29/01/2013 | 12,43 | 12,61 | 12,35 | 12,59 | +1,41% | 2,11% | 337.111 |
| 28/01/2013 | 12,50 | 12,68 | 12,41 | 12,41 | +0,25% | 2,15% | 245.259 |
| 25/01/2013 | 12,25 | 12,39 | 12,07 | 12,38 | +1,69% | 2,60% | 126.797 |
| 24/01/2013 | 12,36 | 12,49 | 12,07 | 12,18 | -1,66% | 3,38% | 66.364 |
| 23/01/2013 | 12,42 | 12,42 | 12,30 | 12,38 | -0,25% | 1,00% | 177.452 |
| 22/01/2013 | 12,58 | 12,61 | 12,36 | 12,41 | -1,53% | 2,03% | 71.334 |
| 18/01/2013 | 12,48 | 12,63 | 12,42 | 12,61 | +0,75% | 1,70% | 117.019 |
| 17/01/2013 | 12,65 | 12,68 | 12,36 | 12,51 | -0,50% | 2,57% | 93.134 |
| 16/01/2013 | 12,74 | 12,79 | 12,48 | 12,58 | -1,56% | 2,40% | 429.604 |
| 15/01/2013 | 12,59 | 12,90 | 12,41 | 12,78 | +0,99% | 3,87% | 97.142 |
| 14/01/2013 | 12,45 | 12,68 | 12,45 | 12,65 | +1,15% | 1,85% | 121.347 |
| 11/01/2013 | 12,65 | 12,66 | 12,46 | 12,51 | -0,99% | 1,58% | 52.578 |
| 10/01/2013 | 12,81 | 12,81 | 12,28 | 12,63 | -0,73% | 4,19% | 116.698 |
| 09/01/2013 | 12,26 | 13,09 | 12,24 | 12,73 | +4,67% | 6,97% | 607.537 |
| 08/01/2013 | 11,90 | 12,17 | 11,87 | 12,16 | +1,72% | 2,52% | 160.300 |